„Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations“. Clin J Pain. 24-jild, № 6. 2008. 479–96-bet. doi:10.1097/AJP.0b013e31816b2f43. PMID18574358.
„Mechanisms of opioid-induced tolerance and hyperalgesia“. Pain Manag Nurs. 8-jild, № 3. September 2007. 113–21-bet. doi:10.1016/j.pmn.2007.02.004. PMID17723928.
Mitra S (2018). „Opioid-induced hyperalgesia: pathophysiology and clinical implications“. J Opioid Manag. 4-jild, № 3. 123–30-bet. doi:10.5055/jom.2008.0017. PMID18717507.
„The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury“. Eur. J. Neurosci. 23-jild, № 4. February 2006. 995–1004-bet. doi:10.1111/j.1460-9568.2006.04623.x. PMID16519664.
„Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes“. Neuroscience. 144-jild, № 1. January 2007. 275–85-bet. doi:10.1016/j.neuroscience.2006.09.016. PMID17069983.
„Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation“. Eur. J. Pharmacol. 510-jild, № 3. March 2005. 223–28-bet. doi:10.1016/j.ejphar.2005.01.033. PMID15763246.
„Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin“. Brain Res. 623-jild, № 2. October 1993. 321–24-bet. doi:10.1016/0006-8993(93)91446-Y. PMID8221116.
„Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites“. Neuropsychopharmacology. 33-jild, № 8. July 2008. 1952–65-bet. doi:10.1038/sj.npp.1301590. PMID17957217.
„The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans“. Pain. 108-jild, № 1–2. March 2004. 148–53-bet. doi:10.1016/j.pain.2003.12.017. PMID15109518.
„Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds“. Acta Anaesthesiol Scand. 51-jild, № 9. October 2007. 1138–46-bet. doi:10.1111/j.1399-6576.2007.01415.x. PMID17714578.
„Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia“. Anesthesiology. 101-jild, № 6. December 2004. 1400–08-bet. doi:10.1097/00000542-200412000-00021. PMID15564948.
„Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers“. Br J Anaesth. 98-jild, № 2. February 2007. 246–54-bet. doi:10.1093/bja/ael344. PMID17251214.
„Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo“. Pain. 72-jild, № 1–2. August 1997. 99–106-bet. doi:10.1016/S0304-3959(97)00006-7. PMID9272793.
„The clinical role of NMDA receptor antagonists for the treatment of postoperative pain“. Best Pract Res Clin Anaesthesiol. 21-jild, № 1. March 2007. 85–98-bet. doi:10.1016/j.bpa.2006.12.006. PMID17489221.
„Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia“. Eur J Pain. 12-jild, № 1. January 2008. 17–29-bet. doi:10.1016/j.ejpain.2007.02.002. PMID17449306.
„Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models“. Drugs in R&D. 8-jild, № 1. 2007. 51–57-bet. doi:10.2165/00126839-200708010-00005. PMID17249849.
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). „Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain“. Current Rheumatology Reports. 10-jild, № 6. 492–99-bet. doi:10.1007/s11926-008-0080-z. PMC2746624. PMID19007541.
Sluka, KA; Chandran, P (November 2002). „Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS“. Pain. 100-jild, № 1–2. 183–90-bet. doi:10.1016/s0304-3959(02)00294-4. PMID12435471.
„Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations“. Clin J Pain. 24-jild, № 6. 2008. 479–96-bet. doi:10.1097/AJP.0b013e31816b2f43. PMID18574358.
„Mechanisms of opioid-induced tolerance and hyperalgesia“. Pain Manag Nurs. 8-jild, № 3. September 2007. 113–21-bet. doi:10.1016/j.pmn.2007.02.004. PMID17723928.
Mitra S (2018). „Opioid-induced hyperalgesia: pathophysiology and clinical implications“. J Opioid Manag. 4-jild, № 3. 123–30-bet. doi:10.5055/jom.2008.0017. PMID18717507.
„The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury“. Eur. J. Neurosci. 23-jild, № 4. February 2006. 995–1004-bet. doi:10.1111/j.1460-9568.2006.04623.x. PMID16519664.
„Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes“. Neuroscience. 144-jild, № 1. January 2007. 275–85-bet. doi:10.1016/j.neuroscience.2006.09.016. PMID17069983.
„Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation“. Eur. J. Pharmacol. 510-jild, № 3. March 2005. 223–28-bet. doi:10.1016/j.ejphar.2005.01.033. PMID15763246.
„Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin“. Brain Res. 623-jild, № 2. October 1993. 321–24-bet. doi:10.1016/0006-8993(93)91446-Y. PMID8221116.
„Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites“. Neuropsychopharmacology. 33-jild, № 8. July 2008. 1952–65-bet. doi:10.1038/sj.npp.1301590. PMID17957217.
„The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans“. Pain. 108-jild, № 1–2. March 2004. 148–53-bet. doi:10.1016/j.pain.2003.12.017. PMID15109518.
„Methylprednisolone and Ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds“. Acta Anaesthesiol Scand. 51-jild, № 9. October 2007. 1138–46-bet. doi:10.1111/j.1399-6576.2007.01415.x. PMID17714578.
„Chronic oral Gabapentin reduces elements of central sensitization in human experimental Hyperalgesia“. Anesthesiology. 101-jild, № 6. December 2004. 1400–08-bet. doi:10.1097/00000542-200412000-00021. PMID15564948.
„Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers“. Br J Anaesth. 98-jild, № 2. February 2007. 246–54-bet. doi:10.1093/bja/ael344. PMID17251214.
„Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary Hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo“. Pain. 72-jild, № 1–2. August 1997. 99–106-bet. doi:10.1016/S0304-3959(97)00006-7. PMID9272793.
„The clinical role of NMDA receptor antagonists for the treatment of postoperative pain“. Best Pract Res Clin Anaesthesiol. 21-jild, № 1. March 2007. 85–98-bet. doi:10.1016/j.bpa.2006.12.006. PMID17489221.
„Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic Hyperalgesia“. Eur J Pain. 12-jild, № 1. January 2008. 17–29-bet. doi:10.1016/j.ejpain.2007.02.002. PMID17449306.
„Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models“. Drugs in R&D. 8-jild, № 1. 2007. 51–57-bet. doi:10.2165/00126839-200708010-00005. PMID17249849.
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). „Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain“. Current Rheumatology Reports. 10-jild, № 6. 492–99-bet. doi:10.1007/s11926-008-0080-z. PMC2746624. PMID19007541.
Sluka, KA; Chandran, P (November 2002). „Enhanced reduction in hyperalgesia by combined administration of clonidine and TENS“. Pain. 100-jild, № 1–2. 183–90-bet. doi:10.1016/s0304-3959(02)00294-4. PMID12435471.
ncbi.nlm.nih.gov
DeSantana, JM; Walsh, DM; Vance, C; Rakel, BA; Sluka, KA (December 2008). „Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain“. Current Rheumatology Reports. 10-jild, № 6. 492–99-bet. doi:10.1007/s11926-008-0080-z. PMC2746624. PMID19007541.